Urology. 2003 Aug;62(2):351.

Management of metastatic malignant melanoma of the bladder.

Lee CS, Komenaka IK, Hurst-Wicker KS, Deraffele G, Mitcham J, Kaufman HL.

Source

Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA.

Abstract

Recombinant interleukin-2 (IL-2) has demonstrated antitumor activity and durable clinical responses in patients with metastatic melanoma. Careful screening and selection of appropriate patients has improved the safety profile of IL-2 administration. Gross hematuria would ordinarily preclude the safe delivery of IL-2. We report a case of metastatic melanoma to the bladder presenting with hematuria. A complete resection was performed and subsequently allowed the administration of high-dose, bolus IL-2. The combination of resection and IL-2 therapy resulted in a partial response maintained for more than 18 months. Symptomatic bladder melanoma should be aggressively treated to allow for systemic immunotherapy, which can provide durable responses.

PMID:: 12893353; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Supplemental Content

Related citations

[Metastatic malignant melanoma of the urinary bladder presenting with hematuria: a case report]. [Hinyokika Kiyo. 2008]
[Metastatic malignant melanoma of the urinary bladder presenting with hematuria: a case report].
Maeda T, Uchida Y, Kouda T, Matsui H, Kawahara Y, Sato T, Nakajima F. Hinyokika Kiyo. 2008 Dec; 54(12):787-90.
A case of metastatic malignant melanoma presenting with hematuria. [Urol Int. 2000]
A case of metastatic malignant melanoma presenting with hematuria.
Demirkesen O, Yaycioglu O, Uygun N, Demir G, Yalcin V. Urol Int. 2000; 64(2):118-20.
Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanoma. [Br J Cancer. 2004]
Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanoma.
Lotem M, Shiloni E, Pappo I, Drize O, Hamburger T, Weitzen R, Isacson R, Kaduri L, Merims S, Frankenburg S, et al. Br J Cancer. 2004 Feb 23; 90(4):773-80.
Review [Metastatic malignant melanoma of the urinary bladder: a case report]. [Nihon Hinyokika Gakkai Zasshi. 2009]
Review [Metastatic malignant melanoma of the urinary bladder: a case report].
Nohara T, Sakai A, Fuse H, Imamura Y. Nihon Hinyokika Gakkai Zasshi. 2009 Nov; 100(7):707-11.
Review Treatment of metastatic malignant melanoma. [Curr Treat Options Oncol. 2005]
Review Treatment of metastatic malignant melanoma.
Atallah E, Flaherty L. Curr Treat Options Oncol. 2005 May; 6(3):185-93.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Management of metastatic malignant melanoma of the bladder.
Management of metastatic malignant melanoma of the bladder.
Urology. 2003 Aug ;62(2):351.

PubMed
The role of the dental surgeon in detecting osteoporosis: the OSTEODENT study.
The role of the dental surgeon in detecting osteoporosis: the OSTEODENT study.
Br Dent J. 2008 May 24 ;204(10):E16; discussion 560-1. Epub 2008 Apr 18 .

PubMed
Long-term treatment with intracavernosal injections in diabetic men with erectil...
Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction.
Asian J Androl. 2006 Mar ;8(2):219-24.

PubMed
The network of glucokinase-expressing cells in glucose homeostasis and the poten...
The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy.
Diabetes. 2006 Jan ;55(1):1-12.

PubMed
A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured perip...
A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.
J Immunol. 2009 Feb 15 ;182(4):2492-501.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Management of metastatic malignant melanoma of the bladder.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Related citations

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information